HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Translational Center To Study Cell-Based Toxicity Tests, Offer Industry Grants

Executive Summary

Toxicity testing is one area in which NIH Director Francis Collins expects the proposed National Center for Advancing Translational Science to help industry speed up drug development.
Advertisement

Related Content

NIH Repurposing Of Failed Compounds Could Begin Soon; NCATS Plans Pilots
NIH Conflict Of Interest Reg Attracts Criticism From Transparency Advocates
NIH Conflict Of Interest Reg Attracts Criticism From Transparency Advocates
NIH Conflict Of Interest Reg Aims To Bolster Public Trust As Links To Industry Flourish
FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg
FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg
Collins Promises To Send NCATS Funding Proposal To Congress Within Weeks
Consolidating Translational Research Programs Is Top FY '12 Priority For NIH
Consolidating Translational Research Programs Is Top FY '12 Priority For NIH
NIH Center Would Seek To Boost “Repurposing” Of Shelved Drug Candidates

Topics

Advertisement
UsernamePublicRestriction

Register

PS053559

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel